©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1629-1636
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1629
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1629
Table 1 Patient demographics and comorbidities
| Variables | Operative group (N = 63) | Nonoperative group (N = 68) | P value |
| Demographics | |||
| Age | 63.3 | 66.7 | |
| Age > 50 yr, n (%) | 57 (90.5) | 53 (78.0) | |
| Male sex, n (%) | 37 (58.7) | 42 (61.8) | |
| Ethnicity | |||
| European | 33 | 44 | |
| Asian | 15 | 4 | 0.013 |
| Pacific Peoples | 6 | 8 | |
| Māori | 7 | 10 | |
| MELAA | 0 | 2 | 0.004 |
| Unknown | 2 | 0 | |
| Tumour location | |||
| Oesophageal | 9 | 19 | |
| Gastro-oesophageal | 10 | 6 | |
| Gastric | 44 | 43 | |
| Pathological stage | |||
| I | 18 | 11 | |
| II | 10 | 6 | |
| III | 30 | 5 | |
| IV | 5 | 46 | < 0.001 |
| Current smoker | 9 | 11 | |
| Charlson Comorbidity Index | 6.5 ± 2.1 | 7.7 ± 2.5 | 0.0073 |
- Citation: Grinlinton M, Furkert C, Maurice A, Angelo N, Booth M. Gastroesophageal signet ring cell carcinoma morbidity and mortality: A retrospective review. World J Gastrointest Surg 2024; 16(6): 1629-1636
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1629.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1629